Literature DB >> 22153808

Local control of experimental malignant pancreatic tumors by treatment with a combination of chemotherapy and intratumoral 224radium-loaded wires releasing alpha-emitting atoms.

Galit Horev-Drori1, Tomer Cooks, Hadas Bittan, Elinor Lazarov, Michael Schmidt, Lior Arazi, Margalit Efrati, Itzhak Kelson, Yona Keisari.   

Abstract

We developed (224)Ra-loaded wires that when inserted into solid tumors, release radioactive atoms that spread in the tumor and irradiate it effectively with alpha particles (diffusing alpha-emitters radiation therapy [DaRT]). In this study, we tested the ability of intratumoral (224)Ra-loaded wires to control the local growth of pancreatic tumors and the enhancement of this effect by chemotherapy. Pancreatic mouse tumors (Panc02) were treated with (224)Ra-loaded wire(s) with or without gemcitabine. The tumor size and survival were monitored, and autoradiography was performed to evaluate the spread of radioactive atoms inside the tumor. Mouse and human pancreatic cancer cells, irradiated in vitro by alpha particles with or without chemotherapy, were evaluated for cell growth inhibition. The insertion of (224)Ra-loaded wires into pancreatic tumors in combination with gemcitabine achieved significant local control and was superior to each treatment alone. A dosimetric analysis showed the spread of radioactive atoms in the tumor around the wires. Alpha particles combined with gemcitabine or 5-FU killed mouse and human cells in vitro better than each treatment alone. DaRT in combination with gemcitabine was proven effective against pancreatic tumors in vivo and in vitro, and the process may be applicable as a palliative treatment for patients with pancreatic cancer.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22153808     DOI: 10.1016/j.trsl.2011.08.009

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  8 in total

1.  212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models.

Authors:  Benjamin B Kasten; Abhishek Gangrade; Harrison Kim; Jinda Fan; Soldano Ferrone; Cristina R Ferrone; Kurt R Zinn; Donald J Buchsbaum
Journal:  Nucl Med Biol       Date:  2017-12-24       Impact factor: 2.408

2.  Enhanced killing of cervical cancer cells by combinations of methyl jasmonate with cisplatin, X or alpha radiation.

Authors:  Elad Milrot; Anna Jackman; Eliezer Flescher; Pinhas Gonen; Itzhak Kelson; Yona Keisari; Levana Sherman
Journal:  Invest New Drugs       Date:  2012-09-06       Impact factor: 3.850

Review 3.  A Critical Review of Alpha Radionuclide Therapy-How to Deal with Recoiling Daughters?

Authors:  Robin M de Kruijff; Hubert T Wolterbeek; Antonia G Denkova
Journal:  Pharmaceuticals (Basel)       Date:  2015-06-10

4.  DDMC-p53 gene therapy with or without cisplatin and microwave ablation.

Authors:  Wolfgang Hohenforst-Schmidt; Paul Zarogoulidis; Joshua Stopek; Thomas Vogl; Frank Hübner; J Francis Turner; Robert Browning; Konstantinos Zarogoulidis; Antonis Drevelegas; Konstantinos Drevelegas; Kaid Darwiche; Lutz Freitag; Harald Rittger
Journal:  Onco Targets Ther       Date:  2015-05-20       Impact factor: 4.147

5.  Combining alpha radiation-based brachytherapy with immunomodulators promotes complete tumor regression in mice via tumor-specific long-term immune response.

Authors:  Vered Domankevich; Adi Cohen; Margalit Efrati; Michael Schmidt; Hans-Georg Rammensee; Sujit S Nair; Ashutosh Tewari; Itzhak Kelson; Yona Keisari
Journal:  Cancer Immunol Immunother       Date:  2019-10-22       Impact factor: 6.968

6.  A New Approach for a Safe and Reproducible Seeds Positioning for Diffusing Alpha-Emitters Radiation Therapy of Squamous Cell Skin Cancer: A Feasibility Study.

Authors:  Giacomo Feliciani; Salvatore Roberto Bellia; Massimo Del Duca; Giorgio Mazzotti; Manuela Monti; Ignazio Stanganelli; Yona Keisari; Itzhak Kelson; Aron Popovtzer; Antonino Romeo; Anna Sarnelli
Journal:  Cancers (Basel)       Date:  2022-01-04       Impact factor: 6.639

7.  Diffusing alpha-emitters radiation therapy in combination with temozolomide or bevacizumab in human glioblastoma multiforme xenografts.

Authors:  Yossi Nishri; Maayan Vatarescu; Ishai Luz; Lior Epstein; Mirta Dumančić; Sara Del Mare; Amit Shai; Michael Schmidt; Lisa Deutsch; Robert B Den; Itzhak Kelson; Yona Keisari; Lior Arazi; Tomer Cooks; Vered Domankevich
Journal:  Front Oncol       Date:  2022-09-27       Impact factor: 5.738

8.  Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies.

Authors:  Wolfgang Hohenforst-Schmidt; Paul Zarogoulidis; Kaid Darwiche; Thomas Vogl; Eugene P Goldberg; Haidong Huang; Michael Simoff; Qiang Li; Robert Browning; Francis J Turner; Patrick Le Pivert; Dionysios Spyratos; Konstantinos Zarogoulidis; Seyhan I Celikoglu; Firuz Celikoglu; Johannes Brachmann
Journal:  Drug Des Devel Ther       Date:  2013-07-18       Impact factor: 4.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.